| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
|
| juillet 2015 - 55 Spécialités |
|
| | | IPro | IPat | | Esomeprazol Spirig HC 20 mg | 14 Comprimé(s) | 5.60 | 14.65 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 20 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | | IPro | IPat | | Esomeprazol Spirig HC 20 mg | 30 Comprimé(s) | 11.00 | 24.95 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 20 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 20 mg | 60 Comprimé(s) | 18.90 | 38.15 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 20 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 20 mg | 100 Comprimé(s) | 30.30 | 51.25 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 20 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 40 mg | 14 Comprimé(s) | 6.20 | 15.35 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 40 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 40 mg | 30 Comprimé(s) | 11.20 | 25.20 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 40 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 40 mg | 60 Comprimé(s) | 20.90 | 40.45 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 40 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 40 mg | 100 Comprimé(s) | 36.90 | 58.80 | 10% | | Comprimés résistants au suc gastrique: Esomeprazolum 40 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Voriconazol Sandoz 200 mg | Flacon perforable | 132.94 | 169.20 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Voriconazolum 200 mg | Sandoz
Pharmaceuticals AG | A / LS / SG | FB | | G | |
| | | IPro | IPat | | ColiFin PARI 2 Mio. U.I. | 56 | 2464.56 | 2767.20 | 10% | | poudre pour solution pour inhalation par nébuliseur: Colistimethatum Natricum 2 Mio UI | PARI Swiss AG | A / LS / SG | FB | | G | |
| | | IPro | IPat | PP | Plegridy Pen, 63 mcg/0.5 ml | Kombipackung(en) | 917.13 | 1068.40 | 10% | | Peginterferonum Beta-1a 63µg / 0.5ml | Biogen Switzerland AG | B / LS | FB | | G | |
| | | IPro | IPat | PP | Plegridy Pen, 125 mcg/0.5 ml | 2 pièce(s) | 955.18 | 1110.20 | 10% | | Peginterferonum Beta-1a 125µg / 0.5ml | Biogen Switzerland AG | B / LS | FB | | G | |
| | | IPro | IPat | | Abasaglar KwikPen 100
U/ml | 5 x 3 ml | 44.37 | 67.40 | 10% | | Solution injectable: Insulinum Glarginum 3.64 mg/ml | Eli Lilly (Suisse) SA | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Moventig 12.5 mg | 30 Comprimé(s) | 76.13 | 103.90 | 10% | | Comprimés filmés: Naloxegolum 12.5 mg | Cederberg GmbH | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Moventig 25 mg | 30 Comprimé(s) | 76.13 | 103.90 | 10% | | Comprimés filmés: Naloxegolum 25 mg | Cederberg GmbH | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Moventig 25 mg | 90 Comprimé(s) | 226.69 | 276.90 | 10% | | Comprimés filmés: Naloxegolum 25 mg | Cederberg GmbH | B / LS | FB | | G | |
| L | | IPro | IPat | | Otezla 30mg | 56 Comprimé(s) | 601.03 | 707.05 | 10% | | Comprimés filmés: Apremilastum 30 mg | Amgen Switzerland AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 5 mg / 500 mg | 28 Comprimé(s) | 23.92 | 43.90 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 5 mg / 500 mg | 98 Comprimé(s) | 83.56 | 112.45 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 10 mg / 500 mg | 28 Comprimé(s) | 47.84 | 71.40 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 10 mg / 500 mg | 98 Comprimé(s) | 167.10 | 208.45 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 5 mg / 1000 mg | 28 Comprimé(s) | 23.92 | 43.90 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 5 mg / 1000 mg | 98 Comprimé(s) | 83.56 | 112.45 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 10 mg / 1000 mg | 28 Comprimé(s) | 47.84 | 71.40 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | PP | Xigduo XR 10 mg / 1000 mg | 98 Comprimé(s) | 167.10 | 208.45 | 10% | | Comprimés filmés: 2 Principes actifs | AstraZeneca AG | B / LS | FB | | G | |
| L | | IPro | IPat | | Otezla 10 mg, 20 mg | 19 Comprimé(s) | 284.43 | 343.25 | 10% | | mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg | Amgen Switzerland AG | B / LS | FB | | G | |
| | | IPro | IPat | PP | Plegridy Pen, 94 mcg/0.5 ml | Kombipackung(en) | DDP | DDP | N.O. | | Peginterferonum Beta-1a 94µg / 0.5ml | Biogen Switzerland AG | B | FB | | G | |
| | | IPro | IPat | | Abasaglar KwikPen 100
U/ml | 5 x 3 ml | 45.30 | 68.40 | N.O. | | Solution injectable: Insulinum Glarginum 3.64 mg/ml | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | IPro | | | Ampres 10 mg/ml | 10 1 ampoule(s) à 5 ml | DDP | DDP | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 30 mg/ml | Flacon perforable à 20 ml | DDP | DDP | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 30 mg/ml | 5 1 ampoule(s) à 20 ml | DDP | DDP | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 20 mg/ml | Flacon perforable à 20 ml | DDP | DDP | N.O. | | Solution injectable: 2 Principes actifs | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 20 mg/ml | 5 1 ampoule(s) à 20 ml | DDP | DDP | N.O. | | Solution injectable: 2 Principes actifs | Sintetica SA | B | FB | | G | |
| | | IPro | | | Oxynorm Inject 10mg/1ml | 5 1 ampoule(s) à 1 ml | DDP | DDP | N.O. | | Solution injectable: Oxycodoni Hydrochloridum 10 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IPro | | | Oxynorm Inject 200mg/20ml | 4 1 ampoule(s) à 20 ml | DDP | DDP | N.O. | | Solution injectable: Oxycodoni Hydrochloridum 200mg / 20ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IPro | | | Oxynorm Inject 50mg/1ml | 5 1 ampoule(s) à 1 ml | DDP | DDP | N.O. | | Solution injectable: Oxycodoni Hydrochloridum 50 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 20 mg | 100 Comprimé(s) | 30.30 | 51.20 | N.O. | | Comprimés résistants au suc gastrique: Esomeprazolum 20 mg | Spirig HealthCare AG | B | FB | | G | |
| | | IPro | IPat | | Esomeprazol Spirig HC 40 mg | 100 Comprimé(s) | 36.90 | 58.75 | N.O. | | Comprimés résistants au suc gastrique: Esomeprazolum 40 mg | Spirig HealthCare AG | B | FB | | G | |
| | | IPro | IPat | | Prezista 100 mg/ml | flacon(s) | DDP | DDP | N.O. | | Suspension (orale): Darunavirum 100 mg/ml | Janssen-Cilag AG | A | FB | | G | |
| | | IPro | IPat | | Algifor Liquid caps 400 | 10 Gélule(s) | DDP | DDP | N.O. | | Capsule de gélatine molle: Ibuprofenum 400 mg | VERFORA SA | D | FB | | G | |
| | | | IPat | H | Viburcol | 15 x 1 ml | DDP | DDP | N.O. | | Flüssigkeit zum Einnehmen: 6 Principes actifs | ebi-pharm ag | D | FB | | G | |
| | | IPro | | | Voriconazol Sandoz 200 mg | 5 Flacon perforable | DDP | DDP | N.O. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Voriconazolum 200 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IPro | | | Voriconazol Sandoz 200 mg | 10 Flacon perforable | DDP | DDP | N.O. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Voriconazolum 200 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IPro | IPat | Ph | Aplona | 20 Sachet(s) | DDP | DDP | N.O. | | Pulver zur Herstellung einer Suspension zum Einnehmen: Mali Fructus Siccati Pulvis 4.9 g | athenstaedt AG | D | FB | | G | |
| | | IPro | IPat | Ph | Aplona | 50 Sachet(s) | DDP | DDP | N.O. | | Pulver zur Herstellung einer Suspension zum Einnehmen: Mali Fructus Siccati Pulvis 4.9 g | athenstaedt AG | D | FB | | G | |
| | | IPro | | PP | Plegridy
63mcg/0.5ml+94mcg/0.5ml | 2 | 1034.37 | 1195.95 | N.O. | | Peginterferonum Beta-1a 94 mcg | Biogen Switzerland AG | B | FB | | G | |
| | | IPro | | PP | Plegridy | 2 | 1077.28 | 1243.00 | N.O. | | Peginterferonum Beta-1a 125 mcg | Biogen Switzerland AG | B | FB | | G | |
| | | IPro | | | Gemcitabine Pharmintraco 200 mg | Flacon perforable | DDP | DDP | N.O. | | Concentrato per soluzione per infusione: Gemcitabinum 200 mg | Pharmintraco Sagl | A | FB | | G | |
| | | IPro | | | Gemcitabine Pharmintraco 200 mg | 10 Flacon perforable | DDP | DDP | N.O. | | Concentrato per soluzione per infusione: Gemcitabinum 200 mg | Pharmintraco Sagl | A | FB | | G | |
| | | IPro | | | Gemcitabine Pharmintraco 1 g | Flacon perforable | DDP | DDP | N.O. | | Concentrato per soluzione per infusione: Gemcitabinum 1000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | IPro | | | Gemcitabine Pharmintraco 1 g | 10 Flacon perforable | DDP | DDP | N.O. | | Concentrato per soluzione per infusione: Gemcitabinum 1000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | IPro | | | Gemcitabine Pharmintraco 2 g | Flacon perforable | DDP | DDP | N.O. | | Concentrato per soluzione per infusione: Gemcitabinum 2000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | IPro | | | Gemcitabine Pharmintraco 2 g | 10 Flacon perforable | DDP | DDP | N.O. | | Concentrato per soluzione per infusione: Gemcitabinum 2000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | IPro | IPat | | Nexium Control 20 mg | 7 Comprimé(s) | DDP | DDP | N.O. | | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Pfizer AG | C | FB | | G | |
| | | IPro | IPat | | Nexium Control 20 mg | 14 Comprimé(s) | DDP | DDP | N.O. | | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Pfizer AG | C | FB | | G | |
